Genome-wide epigenetic landscape of lung adenocarcinoma links HOXB9 DNA methylation to intrinsic EGFR-TKI resistance and heterogeneous responses

SF Su, CH Liu, CL Cheng, CC Ho, TY Yang… - JCO Precision …, 2021 - ascopubs.org
PURPOSE Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show
efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations …
被引用次数：13 相关文章

Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Response

SF Su, CH Liu, CL Cheng, CC Ho, TY Yang… - JCO PRECISION …, 2021 - ir.csmu.edu.tw
PURPOSE Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show
efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations …

Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses.

SF Su, CH Liu, CL Cheng, CC Ho, TY Yang… - JCO Precision …, 2021 - europepmc.org
PURPOSE Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show
efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations …

Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses

SF Su, CH Liu, CL Cheng, CC Ho… - JCO precision …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show
efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations …
[HTML] nih.gov

[HTML][HTML] Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous …

SF Su, CH Liu, CL Cheng, CC Ho, TY Yang… - JCO Precision …, 2021 - ncbi.nlm.nih.gov
PURPOSE Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show
efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations …

Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses.

SF Su, CH Liu, CL Cheng, CC Ho, TY Yang… - JCO Precision …, 2021 - europepmc.org
PURPOSE Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show
efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations …